Author: <span>Mesothelioma News</span>

Eighth annual Miles for Meso 5K raises $40,000 for Asbestos Disease Awareness Organization

The 8th Annual Miles for Meso 5K and 3K Fun Run and Walk did its job in one of the best ways possible: raise awareness for mesothelioma, a terrible and rare type of cancer caused by asbestos, and have a great time while doing so. In the race, which too…

Florida Tightens the Reins on Proving Causation in Asbestos Claims

On September 14, 2016, Florida joined a growing number of jurisdictions that reject the “any exposure” theory of proving causation. Variously known as the “cumulative exposure” or “each and every exposure” theory, it is based on a form of junk science …

The U.S. Environmental Protection Agency to Remove Asbestos from New York Factory

The U.S. Environmental Protection Agency is working to stop the potential spread of asbestos at the former Arkell and Smiths Sack Co. facility in Canajoharie, N.Y. Exposure to asbestos can lead to lung cancer and mesothelioma.

Widow of former Chatham Dockyard worker Tony Bells sues the Ministry of Defence over asbestos claim

The widow of a former Chatham Dockyard worker is appealing for his former colleagues to come forward as she attempts to sue the Ministry of Defence. Tony Bell, 66, died from lung cancer in December 2011 and his wife Janet is now hoping to claim compens…

SELLAS Life Sciences Group Receives FDA Fast Track Designation Of…

The FDA’s Fast Track program is an expedited drug development and review program for new drugs or biologics which show promise in treating serious or life-threatening conditions and address an unmet medical need. Galinpepimut-S, SELLAS’ WT1 cancer vaccine, is a late clinical-stage immunotherapy being developed to target hematologic cancers and solid tumors, including MPM, AML, multiple myeloma, ovarian and other cancers.

Family gives part of asbestos settlement to hospice who cared for dad

A FACTORY worker’s family has agreed a five-figure out-of-court settlement over his death from asbestos-related disease. Michael Puddicombe died in March last year, aged 65, after a two-year battle with mesothelioma, a cancer caused by exposure to asbestos decades ago when he was working in a brake pad factory.

Man exposed to asbestos died of industrial disease, inquests concludes

A Pakenham man made a statement before his death in which he spoke about exposure to asbestos which went on to cause his fatal condition, an inquest has heard. Brian Buckle, 75, died at his home in Fen Road, on May 16, the inquest at Bury St Edmunds wa…

Home renovation TV programs put on notice about asbestos

The Australian Asbestos Safety and Eradication Agency is warning of another wave of mesothelioma cases amongst home renovators who are failing to recognise asbestos products. The Agency’s CEO, Peter Tighe says their latest research indicates that Do it Yourself home renovators are more ignorant about asbestos dangers than they were two years ago.

Women with breast cancer have 80% chance of being alive 10 years after diagnosis.

National data experts have – for the first time – predicted how many people with cancer can expect to survive a decade. The new figures, from the Office for National Statistics , show what proportion of people newly-diagnosed in 2015 can expect to surv…

Study of potential new treatment for mesothelioma open to patients

The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy. Pleural mesothelioma is a rare and aggressive cancer that develops in the pleura, a thin layer of tissue that surrounds the lungs.

Study of potential new treatment for mesothelioma open to patients

The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy. Pleural mesothelioma is a rare and aggressive cancer that develops in the pleura, a thin layer of tissue that surrounds the lungs.